Astilbin, a dihydroflavonol derivative from Rhizoma Smilacis glabrae (Tu-Fu-Ling in Chinese), significantly improves cerebral infarction and neurological deficits, and inhibits apoptosis and inflammation after I/R injury by activating the PI3K/AKT pathway (106). Here, AKT1 is linked to brain infarction.